Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

New pharmaceutical target reverses osteoporosis in mice

Science Daily - 21 Aug 2019 23:37
Biomedical engineers have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.
Full Article at Science Daily

More Medical News
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard